TSS
AYTU icon

Two Sigma Securities’s AYTU BioPharma AYTU Stock Holding History

Two Sigma Securities’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,690
Closed -$19.9K – 1470
2024
Q4 		$19.9K Buy
+11,690
New +$21.4K ﹤0.01% 1324
2022
Q4 		– Sell
-1,026
Closed -$4K – 2575
2022
Q3 		$4K Buy
+1,026
New +$7.78K ﹤0.01% 2486
2020
Q4 		– Sell
-101
Closed -$24K – 1661
2020
Q3 		$24K Buy
+101
New +$26K ﹤0.01% 1229
2018
Q3 		– Sell
-13
Closed -$13K – 2577
2018
Q2 		$13K Buy
+13
New +$21.7K ﹤0.01% 2573

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Securities's AYTU Position: Q1 2025 in Review

Two Sigma Securities sold out of AYTU BioPharma (AYTU) in Q1 2025, closing a stake of 11,690 shares — an estimated $19.9K sold.

Two Sigma Securities first reported a position in AYTU in Q2 2018 and held it in 4 quarters. The position peaked at $24K in Q3 2020. 31 funds tracked by Wall St. Rank hold AYTU as of Q1 2025.

  • Two Sigma Securities reported no remaining AYTU BioPharma position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 11,690 AYTU BioPharma shares in Q1 2025, an estimated $19.9K.
  • Two Sigma Securities first reported a position in AYTU BioPharma in Q2 2018 and held it in 4 quarters.
  • Two Sigma Securities's AYTU BioPharma position peaked at $24K in Q3 2020.
  • 31 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.